1-5 of 5
Authors: Rafael Delgado
Sort by
Journal Article
Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study)
Rocio Montejano and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 12, December 2021, Pages 3263–3271, https://doi.org/10.1093/jac/dkab323
Published: 30 August 2021
Journal Article
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study
David Rial-Crestelo and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 3, March 2021, Pages 738–742, https://doi.org/10.1093/jac/dkaa479
Published: 17 November 2020
Journal Article
HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations
Get access
César Garriga and others
Journal of Antimicrobial Chemotherapy, Volume 64, Issue 2, August 2009, Pages 251–258, https://doi.org/10.1093/jac/dkp200
Published: 07 June 2009
Journal Article
Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression
Get access
Federico Pulido and others
Journal of Antimicrobial Chemotherapy, Volume 61, Issue 6, June 2008, Pages 1359–1361, https://doi.org/10.1093/jac/dkn103
Published: 13 March 2008
Journal Article
Glycodendritic structures: promising new antiviral drugs
Javier Rojo and Rafael Delgado
Journal of Antimicrobial Chemotherapy, Volume 54, Issue 3, September 2004, Pages 579–581, https://doi.org/10.1093/jac/dkh399
Published: 01 September 2004
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals